scholarly article | Q13442814 |
P2093 | author name string | Astar Winoto | |
Gavin M Lewis | |||
Sue J Sohn | |||
P2860 | cites work | BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C | Q24532869 |
Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects | Q24534817 | ||
Knockout of ERK5 causes multiple defects in placental and embryonic development | Q24791222 | ||
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes | Q28203083 | ||
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor | Q28286729 | ||
Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway | Q28508107 | ||
Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor | Q28512848 | ||
ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression | Q28591302 | ||
Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain | Q33605384 | ||
A requirement for sustained ERK signaling during thymocyte positive selection in vivo | Q34015960 | ||
Nuclear hormone receptors in T lymphocytes | Q34126046 | ||
Positive and negative selection of T cells | Q34157557 | ||
Apoptosis during lymphoid development | Q35084288 | ||
In vivo and in vitro clonal deletion of double-positive thymocytes | Q36231231 | ||
Rapid deletion of rearranged T cell antigen receptor (TCR) Valpha-Jalpha segment by secondary rearrangement in the thymus: role of continuous rearrangement of TCR alpha chain gene and positive selection in the T cell repertoire formation. | Q36322809 | ||
Positive and negative selection invoke distinct signaling pathways. | Q36367050 | ||
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation | Q36376229 | ||
Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen | Q36511048 | ||
During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain | Q36639961 | ||
Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. | Q37370471 | ||
Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling | Q39773899 | ||
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. | Q40323778 | ||
A motif in the alphabeta T-cell receptor controls positive selection by modulating ERK activity | Q40862851 | ||
Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase | Q42590095 | ||
Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway | Q43691664 | ||
Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. | Q43967840 | ||
Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. | Q44556255 | ||
A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection | Q44593628 | ||
GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation | Q46044258 | ||
Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells. | Q46697159 | ||
Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice | Q48032387 | ||
The role of erk1 and erk2 in multiple stages of T cell development. | Q50954940 | ||
The Central Tolerance Response to Male Antigen in Normal Mice Is Deletion and Not Receptor Editing | Q53854162 | ||
Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. | Q53877408 | ||
T cell tolerance by clonal elimination in the thymus | Q56922465 | ||
Failure of HY-Specific Thymocytes to Escape Negative Selection by Receptor Editing | Q57078475 | ||
Duration and Strength of Extracellular Signal-Regulated Kinase Signals Are Altered During Positive Versus Negative Thymocyte Selection | Q59123070 | ||
B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes | Q71616339 | ||
Receptor editing in developing T cells | Q73035421 | ||
Degree of ERK activation influences both positive and negative thymocyte selection | Q73666616 | ||
LKLF: A transcriptional regulator of single-positive T cell quiescence and survival | Q73709468 | ||
CD3delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection | Q74144662 | ||
Defective central tolerance induction in NOD mice: genomics and genetics | Q81552095 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thymocyte | Q7799635 |
P304 | page(s) | 1896-1906 | |
P577 | publication date | 2008-06-12 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis | |
P478 | volume | 27 |
Q33523813 | A novel TCR transgenic model reveals that negative selection involves an immediate, Bim-dependent pathway and a delayed, Bim-independent pathway |
Q89978308 | ASK1 Mediates Nur77 Expression in T-Cell Receptor Mediated Thymocyte Apoptosis |
Q54636641 | Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells |
Q42378808 | Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity |
Q34662225 | CBAP promotes thymocyte negative selection by facilitating T-cell receptor proximal signaling |
Q35874330 | CCR7/CCL19 controls expression of EDG-1 in T cells |
Q92957674 | Caenorhabditis elegans and its applicability to studies on restless legs syndrome |
Q36862130 | Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site |
Q38841260 | Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface |
Q37618290 | ERK and cell death: ERK location and T cell selection |
Q37618297 | ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence |
Q37977186 | ERK5 and its role in tumour development |
Q35651895 | Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma |
Q42051316 | Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis. |
Q54611374 | Injury-induced activation of the MAPK/CREB pathway triggers apoptosis-induced compensatory proliferation in hydra head regeneration. |
Q34361180 | Life and death in the thymus—cell death signaling during T cell development |
Q39816876 | MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2. |
Q61796855 | MEK5/ERK5 activation regulates colon cancer stem-like cell properties |
Q34769445 | Modulation of protein kinase signaling cascades by palytoxin |
Q37801270 | Molecular and genetic parameters defining T-cell clonal selection |
Q36850002 | Protein Kinase C ζ Interacts with a Novel Binding Region of Gαq to Act as a Functional Effector |
Q34790083 | Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis |
Q37376338 | Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. |
Q37395668 | TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections |
Q41263307 | Trx1/TrxR1 system regulates post-selected DP thymocytes survival by modulating ASK1-JNK/p38 MAPK activities |